| 000 | 01812 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516170553.0 | ||
| 264 | 0 | _c20140107 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a2168-6114 | ||
| 024 | 7 |
_a10.1001/jamainternmed.2013.10074 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Mulder, Maarten | |
| 245 | 0 | 0 |
_aIntensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial. _h[electronic resource] |
| 260 |
_bJAMA internal medicine _cNov 2013 |
||
| 300 |
_a1896-904 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcute Coronary Syndrome _xcomplications |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 |
_aCreatine Kinase _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xcomplications |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
| 650 | 0 | 4 | _aMyocardial Perfusion Imaging |
| 650 | 0 | 4 |
_aMyocardium _xpathology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aTroponin T _xblood |
| 700 | 1 | _aUmans, Victor A | |
| 700 | 1 | _aCornel, Jan H | |
| 700 | 1 | _avan der Zant, Friso M | |
| 700 | 1 | _aStam, Frank | |
| 700 | 1 | _aOemrawsingh, Rohit M | |
| 700 | 1 | _aAkkerhuis, K Martijn | |
| 700 | 1 | _aBoersma, Eric | |
| 773 | 0 |
_tJAMA internal medicine _gvol. 173 _gno. 20 _gp. 1896-904 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamainternmed.2013.10074 _zAvailable from publisher's website |
| 999 |
_c23071829 _d23071829 |
||